At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...

One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.

Jace, from Connecticut, is one of four children all born with severe childhood blindness who gained 'life-changing improvements' to their vision after an experimental trial of gene therapy.

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute of Ophthalmology and Moorfields Eye Hospital, with ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

The move comes after Commission Chairman Clint Didier invited a group of vaccine skeptics to speak at two recent meetings. It’s the same group behind recent pushes in Idaho to stop offering the ...

The procedure, developed by UCL scientists, consists of injecting healthy copies of the gene into the retina, at the back of ...

The Franklin County Board of Commissioners has passed a resolution urging the Benton Franklin Health District (BFHD) to cease providing, funding, and promoting gene-therapy vaccines until ...

Workplace Bullying's Sleep Impact Spreads to Partners, reveals studyWorkplace bullying affects not only the employee’s sleep ...

US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...

Jace, 4, from Connecticut, was registered legally blind and only just able to distinguish between dark and light before undergoing treatment at Moorfields Eye Hospital in London ...

Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle Eastern, and Indian descent.Despite its widespread impact, SCD research has ...